Go to the list of all blogs
Joma Foster's Avatar
published in Blogs
Aug 03, 2026
Teradyne (TER) Eyes $500 as AI Testing Demand Builds Momentum

Teradyne (TER) Eyes $500 as AI Testing Demand Builds Momentum

Key Takeaways

  • Teradyne closed at $367.69 on July 31, 2026, meaning a move to $500 requires roughly 36% upside from current levels.
  • The all-time high of $487.91, set on June 30, 2026, demonstrates that $500 is within the stock's recent trading range and represents a realistic psychological milestone.
  • AI-driven demand for semiconductor test equipment remains the dominant bullish catalyst, with approximately 70% of company revenue tied to artificial intelligence-related chip testing.
  • Record Q2 2026 revenue of $1.33 billion (up 104% year-over-year) and EPS of $2.47 show powerful operating momentum, though sequential growth has begun to moderate.
  • Valuation at roughly 50 times trailing earnings leaves little margin for error; any slowdown in AI capital expenditure or guidance miss could trigger sharp corrections.
  • Several Wall Street firms, including UBS and Susquehanna, have already placed price targets at or above $500, lending institutional credibility to the level.

The Significance of the $500 Level

The $500 price level carries both psychological and technical significance for Teradyne, Inc. (TER), the Massachusetts-based leader in automated semiconductor test equipment and industrial robotics. On June 30, 2026, the stock reached an all-time intraday high of $487.91 before pulling back sharply. Having come within roughly 2.5% of the $500 mark, the stock established that level as the next major round-number target that traders and investors are actively watching.

Round numbers like $500 often function as both magnets and resistance zones in equity markets. They attract attention from institutional traders, options market participants, and retail investors alike. For Teradyne, reaching $500 would also represent a market capitalization exceeding $78 billion, cementing its position among the semiconductor industry's most valued equipment suppliers.

Teradyne's Position in the Market

Teradyne designs, manufactures, and sells automated test equipment (ATE) that semiconductor manufacturers use to verify chip quality and performance before products ship to customers. Its Semiconductor Test segment, which accounted for roughly 84% of revenue in the most recent quarter, serves integrated device manufacturers, fabless chip designers, and foundries including major players such as Taiwan Semiconductor Manufacturing Company (TSM). The Robotics segment provides collaborative robotic arms and autonomous mobile robots for manufacturing and logistics customers.

The company operates in an effective global duopoly alongside Japan-based Advantest, and the increasing complexity of AI chips — including GPUs, high-bandwidth memory (HBM), and advanced packaging — is structurally expanding the intensity of semiconductor testing. CEO Greg Smith recently noted that AI accelerators demand roughly four times the test content of a standard data-center processor, a dynamic that directly benefits Teradyne's revenue per chip. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Drivers for Further Gains

Teradyne's fundamental trajectory provides a credible foundation for the $500 target. Second-quarter 2026 revenue reached $1.33 billion, more than doubling from the prior-year period. The company guided third-quarter revenue to a range of $1.2 billion to $1.3 billion. For the full year, management has indicated revenue near $6 billion, implying an annual run rate that is unprecedented in the company's six-decade history.

Beyond the core AI test market, emerging opportunities in co-packaged optics (CPO) — integrating optical connections directly onto switch and accelerator packages — could open a new addressable market estimated at $100 million in 2026 and potentially exceeding $1 billion by decade's end. Teradyne's addition to the Nasdaq-100 Index in June 2026 also generates passive institutional buying pressure that supports the stock.

Wall Street increasingly shares the bullish view. UBS raised its price target to $500 in July, while Cantor Fitzgerald and Susquehanna each set targets at $550. Goldman Sachs lifted its target to $465 and Bank of America moved to $525. The consensus analyst target now sits near $450, with 12 of 17 analysts rating the stock a Buy or Strong Buy.

Potential Headwinds to Consider

Despite impressive headline numbers, cautionary signals exist. After reporting a record Q1 2026 with $1.28 billion in revenue, the stock fell 19% in a single day because management's forward guidance implied a sequential revenue decline. The pattern highlights how premium valuations magnify the market's sensitivity to any perception of slowing momentum.

At approximately 50 times trailing earnings and nearly 40 times forward EV/EBITDA (enterprise value to earnings before interest, taxes, depreciation, and amortization), Teradyne trades at a premium even within the richly valued semiconductor equipment sector. The stock's beta of 1.78 indicates volatility nearly 80% higher than the broader market, a characteristic reinforced by the recent swing from the $487.91 high to a low near $297 within a matter of weeks.

Concentration risk represents another structural concern. With roughly 70% of revenue tied to AI-related demand, a slowdown in hyperscaler capital expenditure or a delay in a single large customer program could disproportionately impact quarterly results. Competition from Advantest, particularly in GPU testing, remains intense. Additionally, the robotics segment, while growing at 33%, remains a relatively small contributor that cannot offset a potential semiconductor test slowdown.

Key Technical Levels

From a technical perspective, the $500 level sits just above the established all-time high of $487.91. Support zones formed near $300 during the July pullback represent the floor that must hold for the bullish structure to remain intact. The 200-day moving average near $338 provides an intermediate reference level that institutional investors often monitor. A sustained move above $430–$440, where the stock encountered resistance in late June, would likely be a prerequisite before any credible challenge of $500.

Final Assessment

Teradyne reaching $500 is a realistic intermediate-term scenario backed by powerful secular tailwinds in AI chip testing, expanding test intensity per chip, and credible Wall Street support. The stock has already demonstrated the capacity to trade within 2.5% of that level, and the fundamental revenue trajectory — if sustained — could justify a valuation that supports $500 and beyond. However, the path is unlikely to be smooth. Premium multiples, high AI revenue concentration, and a demonstrated pattern of post-earnings volatility mean that any disappointment around quarterly guidance or AI spending narratives could delay or derail the move. Investors should monitor semiconductor equipment spending data, Teradyne's backlog commentary, and analyst revisions for signals about whether the buy-rate inflection that underpins the bull case remains on track.

Using AI Tools in My Analysis

In my own research process, Tickeron’s AI Daily Buy/Sell Signals provide a systematic way to monitor shifting conditions across volatile stocks like TER. The platform’s AI models help flag emerging patterns and adapt to changing market behavior, which I find useful alongside traditional fundamental work.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations
Related Ticker: TER

TER in upward trend: 10-day moving average moved above 50-day moving average on September 28, 2026

The 10-day moving average for TER crossed bullishly above the 50-day moving average on September 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 85%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 16, 2026. You may want to consider a long position or call options on TER as a result. In 61 of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 69%.

The Moving Average Convergence Divergence (MACD) for TER just turned positive on September 18, 2026. Looking at past instances where TER's MACD turned positive, the stock continued to rise in 34 of 48 cases over the following month. The odds of a continued upward trend are 71%.

TER moved above its 50-day moving average on September 18, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +12.01% 3-day Advance, the price is estimated to grow further. Considering data from situations where TER advanced for three days, in 254 of 315 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

The Aroon Indicator entered an Uptrend today. In 266 of 317 cases where TER Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 84%.

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TER declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 66%.

TER broke above its upper Bollinger Band on October 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 8 (best 1 - 100 worst), indicating outstanding price growth. TER’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 21 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock better than average.

The Tickeron PE Growth Rating for this company is 25 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 28 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 76 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: TER's P/B Ratio (18.248) is slightly higher than the industry average of (8.078). P/E Ratio (55.124) is within average values for comparable stocks, (161.623). Projected Growth (PEG Ratio) (0.734) is also within normal values, averaging (0.801). Dividend Yield (0.001) settles around the average of (0.002) among similar stocks. P/S Ratio (12.077) is also within normal values, averaging (27.897).

Notable companies

The most notable companies in this group are Lam Research Corp (NASDAQ:LRCX), Applied Materials (NASDAQ:AMAT), KLA Corporation (NASDAQ:KLAC), Teradyne (NASDAQ:TER), Ambarella (NASDAQ:AMBA).

Industry description

The electronic production equipment industry makes equipment used to produce semiconductors. Such equipment includes wafer fabrication, plasma etching and photo-resist processing equipment. The industry also makes chemical vapor deposition processing systems and photomasks, which are high-purity quartz plates that contain patterns to define integrated circuits layouts. Applied Materials, Inc., Lam Research Corporation, and KLA-Tencor Corporation are examples of electronic production equipment manufacturing companies.

Market Cap

The average market capitalization across the Electronic Production Equipment Industry is 63.66B. The market cap for tickers in the group ranges from 326.86K to 671.68B. ASML holds the highest valuation in this group at 671.68B. The lowest valued company is AVSR at 326.86K.

High and low price notable news

The average weekly price growth across all stocks in the Electronic Production Equipment Industry was 3%. For the same Industry, the average monthly price growth was 11%, and the average quarterly price growth was 12%. INTT experienced the highest price growth at 28%, while SMTK experienced the biggest fall at -30%.

Volume

The average weekly volume growth across all stocks in the Electronic Production Equipment Industry was 15%. For the same stocks of the Industry, the average monthly volume growth was -12% and the average quarterly volume growth was -63%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 63
P/E Growth Rating: 34
Price Growth Rating: 42
SMR Rating: 71
Profit Risk Rating: 59
Seasonality Score: 27 (-100 ... +100)
View a ticker or compare two or three
TER
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

an electronic test systems manufacturer

Industry ElectronicProductionEquipment

Industry
Electronic Production Equipment
Address
600 Riverpark Drive
Phone
+1 978 370-2700
Employees
6600
Web
https://www.teradyne.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.
As I review BeOne Medicines AG's position in the oncology space, what stands out is its role as a global leader with a diversified portfolio that includes both commercial-stage therapies and a deep pipeline targeting hematologic and solid tumors. The flagship product, BRUKINSA (zanubrutinib), a Bruton's Tyrosine Kinase (BTK) inhibitor, has secured approvals in over 75 markets, solidifying its dominance in chronic lymphocytic leukemia (CLL) and other blood cancers. This is complemented by TEVIMBRA (tislelizumab), an anti-PD-1 antibody approved in more than 50 markets for various indications, which broadens its reach in immunotherapy.
Rio Tinto holds a premier position as one of the world's largest mining companies, anchored by low-cost, Tier 1 assets. Its Pilbara iron ore operations in Australia deliver industry-leading margins, thanks to integrated rail and port infrastructure that gives it a structural cost advantage over higher-cost producers. In copper, the company has significant stakes in Escondida, the world's largest copper mine, and full ownership of Oyu Tolgoi in Mongolia, setting it up well to benefit from tightening supply as demand surges for electrification and renewables.
I've always been impressed by how Visa (V) commands the global payments landscape. As an open-loop network, it connects issuers, acquirers, merchants, and consumers without issuing cards or extending credit itself. The VisaNet platform processes over 65,000 transactions per second across more than 200 countries, supporting a ~52% share of the global credit card market and ~60% of debit. This scale generates powerful network effects, where greater adoption benefits everyone involved and creates formidable barriers to entry.
Following the Kenvue consumer health spin-off, Johnson & Johnson has transformed into a focused healthcare leader, emphasizing Innovative Medicine (pharmaceuticals) and MedTech (devices). In my view, this repositioning sharpens the company's edge in high-margin areas such as oncology, immunology, neuroscience, cardiovascular, surgery, and vision, where its diversified portfolio and R&D efficiency provide clear competitive advantages.
I've long appreciated ASML Holding N.V.'s dominant position in the semiconductor lithography market. The company commands over 90% share in advanced deep ultraviolet (DUV) immersion systems and 100% in EUV lithography—the critical technology for chips below 7nm nodes used in AI, high-performance computing, and memory. This near-monopoly comes from decades of R&D investment, exclusive partnerships like Zeiss for optics, and a vast installed base that generates steady service revenue. From what I see, competitors such as Nikon and Canon remain far behind in EUV, sticking to mature nodes.
I've been watching Micron Technology (MU) closely through its recent volatility, which mirrors the semiconductor sector's heightened sensitivity to AI demand and supply constraints. The stock saw a sharp post-earnings sell-off tied to elevated capital expenditure plans, yet it has rebounded with surging DRAM prices—up 90-95%—and memory suppliers booked out for years. From what I see, broader tech optimism, including key partnerships and persistent supply tightness, is driving upward momentum. This positions MU as a pivotal player in high-bandwidth memory (HBM) for data centers. Trading near recent highs around $368, the shares highlight investor focus on Micron's critical role in the AI infrastructure expansion under these constrained industry conditions.